Baker Bros. Advisors’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-892,579
| Closed | -$4.78M | – | 105 |
|
|
2023
Q2 | $4.78M | Hold |
892,579
| – | – | 0.03% | 73 |
|
|
2023
Q1 | $6.4M | Hold |
892,579
| – | – | 0.03% | 65 |
|
|
2022
Q4 | $5.99M | Hold |
892,579
| – | – | 0.04% | 73 |
|
|
2022
Q3 | $3.09M | Hold |
892,579
| – | – | 0.02% | 92 |
|
|
2022
Q2 | $2.63M | Buy |
892,579
+450,000
| +102% | +$2.37M | 0.01% | 91 |
|
|
2022
Q1 | $3.9M | Hold |
442,579
| – | – | 0.02% | 93 |
|
|
2021
Q4 | $7.1M | Hold |
442,579
| – | – | 0.03% | 85 |
|
|
2021
Q3 | $9.27M | Buy |
442,579
+241,900
| +121% | +$5.83M | 0.04% | 79 |
|
|
2021
Q2 | $5.39M | Hold |
200,679
| – | – | 0.02% | 95 |
|
|
2021
Q1 | $6.39M | Hold |
200,679
| – | – | 0.03% | 87 |
|
|
2020
Q4 | $4.59M | Buy |
+200,679
| New | +$4.62M | 0.02% | 95 |
|
|
2019
Q2 | – | Sell |
-302,600
| Closed | -$5.44M | – | 105 |
|
|
2019
Q1 | $5.44M | Buy |
+302,600
| New | +$5.23M | 0.03% | 58 |
|
|
2018
Q3 | – | Sell |
-217,695
| Closed | -$4.5M | – | 108 |
|
|
2018
Q2 | $4.5M | Sell |
217,695
-145,981
| -40% | -$3.29M | 0.03% | 80 |
|
|
2018
Q1 | $9.15M | Hold |
363,676
| – | – | 0.08% | 61 |
|
|
2017
Q4 | $6.91M | Hold |
363,676
| – | – | 0.06% | 69 |
|
|
2017
Q3 | $6.72M | Hold |
363,676
| – | – | 0.05% | 68 |
|
|
2017
Q2 | $6.37M | Hold |
363,676
| – | – | 0.06% | 59 |
|
|
2017
Q1 | $6.76M | Hold |
363,676
| – | – | 0.06% | 59 |
|
|
2016
Q4 | $7.43M | Hold |
363,676
| – | – | 0.07% | 56 |
|
|
2016
Q3 | $10.9M | Hold |
363,676
| – | – | 0.1% | 53 |
|
|
2016
Q2 | $9.82M | Hold |
363,676
| – | – | 0.1% | 54 |
|
|
2016
Q1 | $6.82M | Hold |
363,676
| – | – | 0.07% | 66 |
|
|
2015
Q4 | $11.3M | Buy |
363,676
+15,900
| +5% | +$483K | 0.09% | 60 |
|
|
2015
Q3 | $7.45M | Buy |
347,776
+42,733
| +14% | +$1.34M | 0.07% | 68 |
|
|
2015
Q2 | $11.6M | Hold |
305,043
| – | – | 0.1% | 60 |
|
|
2015
Q1 | $9.57M | Sell |
305,043
-6,848
| -2% | -$232K | 0.08% | 58 |
|
|
2014
Q4 | $10.9M | Hold |
311,891
| – | – | 0.11% | 47 |
|
|
2014
Q3 | $6.52M | Hold |
311,891
| – | – | 0.08% | 54 |
|
|
2014
Q2 | $6.78M | Buy |
311,891
+215,726
| +224% | +$4.54M | 0.08% | 57 |
|
|
2014
Q1 | $2.68M | Sell |
96,165
-3,835
| -4% | -$135K | 0.03% | 84 |
|
|
2013
Q4 | $2.74M | Buy |
+100,000
| New | +$2.62M | 0.04% | 75 |
|
Other funds holding MGNX
BG
AC
FLSM
WA
Baker Bros. Advisors's MGNX Position: Q3 2023 in Review
Baker Bros. Advisors sold out of MacroGenics (MGNX) in Q3 2023, closing a stake of 892,579 shares — an estimated $4.78M sold.
Baker Bros. Advisors first reported a position in MGNX in Q4 2013 and held it in 31 quarters. The position peaked at $11.6M in Q2 2015. 127 funds tracked by Wall St. Rank hold MGNX as of Q3 2023.
- Baker Bros. Advisors reported no remaining MacroGenics position as of Q3 2023 after selling out during the quarter.
- Baker Bros. Advisors sold 892,579 MacroGenics shares in Q3 2023, an estimated $4.78M.
- Baker Bros. Advisors first reported a position in MacroGenics in Q4 2013 and held it in 31 quarters.
- Baker Bros. Advisors's MacroGenics position peaked at $11.6M in Q2 2015.
- 127 funds tracked by Wall St. Rank held MacroGenics as of Q3 2023.
Based on Baker Bros. Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.